Clinical Studies in Non-small Cell Lung Cancer: The CALGB Experience

References

• Ginsberg R, Vokes E E, Raben A. Non-small cell lung cancer. Cancer-Principles and Practice of Oncology 5th Edition, V T DeVita, Jr, S Hellman, S A Rosenberg. J.B. Lippincott Co., Philadelphia 1997; 858–910
   Google Scholar
• Haraf D J, Devine S M, Ihde D C, Vokes E E. The evolving role of systemic therapy in carcinoma of the lung. Semin Oncol 1992; 19(Suppl 11)72–87
   PubMedGoogle Scholar
• Strauss G M, Langer M P, Elias A D, Skarin A T, Sugarbaker D J. Multimodality treatment of stage IIIA non-small cell lung carcinoma: A critical review of the literature and strategies for future research. J Clin Oncol 1992; 10: 829–838
   PubMed Web of Science ®Google Scholar
• Vokes E E, Bitran J D. Non-small cell lung cancer: towards the next plateau. Chest 1994; 106: 659–661, (editorial)
   PubMed Web of Science ®Google Scholar
• Cormier Y, Bergeron D, La Forge J, Lavandier M, Fournier M, Chenard J, Desmeules M. Benefits of polychemotherapy in advanced non-small-cell bronchogenic carcinoma. Cancer 1982; 50: 845–849
   PubMed Web of Science ®Google Scholar
• Rapp E, Pater J L, Willan A, Cormier Y, Murray N, Evans W K, Hodson D I, Clark D A, Feld R, Arnold A M, Ayoub Jl, Wilson K S, Latreille J, Wierzbicki R F, Hill D P. Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer- Report of a Canadian Multicenter Randomized Trial. J Clin Oncol 1988; 6: 633–641
   PubMed Web of Science ®Google Scholar
• Quoix E, Dietemann A, Charbonneau J, et al. La chimiotherapie comportant du cisplatine est-elle utile dans le cancer bronchique non microcellulaire au stade IV? Resultants d'une etude ran-domisee. Bull Cancer 1991; 78: 341–346
   PubMedGoogle Scholar
• Cartei G, Cartei F, Cantone A, Causarano D, Genco G, Tobaldin A, Interlandi G, Giraldi T. Cisplatin-cyclophosphamide-mitomycin combination chemotherapy with supportive care versus supportive care alone for treatment of metastatic non-small-cell lung cancer. J Natl Cancer Inst 1993; 85: 794–800
   PubMed Web of Science ®Google Scholar
• Grilli R, Oxman A D, Julian J M. Chemotherapy for advanced non-small cell lung cancer: How much benefit is enough?. J Clin Oncol, 11: 1866–1872
   PubMed Web of Science ®Google Scholar
• Souquet P J, Chauvin F, Boissel J P, Cellerino R, Cormier Y, Ganz P A, Pater J L, Quoix E, Rapp E, Tumarello D, Williams J, Woods B L, Bernard J P. Polychemotherapy in advanced non-small cell lung cancer: A meta-analysis. Lancet 1993; 342: 19–21
   PubMed Web of Science ®Google Scholar
• Marino P, Pampallona S, Prestoni A, Cantoni A, Invernizzi F. Chemotherapy versus supportive care in advanced non-small cell lung cancer. Results of a meta-analysis of the literature. Chest 1994; 106: 861–865
   PubMed Web of Science ®Google Scholar
• Stewart L A, Pignon J P, Parmar A KB, Le Chevalier T, Souhami R L. on behalf of the NSCLC Collaborators Group: A metaanalysis using individual patient data from randomised clinical trials of chemotherapy in non-small cell lung cancer: Survival in the supportive care setting. Proc Am Soc Clin Oncol 1994; 13, (abstract)
   Google Scholar
• Dillman R O, Seagreen S L, Propert K J, Guerra J, Eaton W L, Perry M C, Carey R W, Frei E F, III, Green M R. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small cell lung cancer. N Engl J Med 1990; 323: 940–945
   PubMed Web of Science ®Google Scholar
• Le Chevalier T, Arriagada R, Quoix E, et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: First analysis of a randomized trial in 353 patients. J Natl Cancer Inst 1991; 83: 417–423
   PubMed Web of Science ®Google Scholar
• Le Chevalier T, Arriagada R, Tarayre M, Lacombe-Terrier M J, Laplanche A, Quoix E, Ruffle P, Martin M, Douillard J Y. Significant effect of adjuvant chemotherapy on survival in locally advanced non-small-cell lung carcinoma. J Natl Cancer Inst 1992; 84: 58
   PubMed Web of Science ®Google Scholar
• Sause W T, Scott C, Taylor S, et al. Radiation Therapy Oncology Group (RTOG) 8808 and Eastern Cooperative Oncology Group (ECOG) 4588, Preliminary results of a phase HI trial in regionally advanced, unresectable non-small-cell lung cancer. J Natl Cancer Inst 1995; 87: 198–205
   PubMed Web of Science ®Google Scholar
• Schaake-Koning C, Van den Bogaert W, Dalesio O, Festen J, Hoogenhout J, Van Houtte P, Kirkpatrick A, Koolen M, Maat B, Nijs A, Renaud A, Rodrigus P, Schuster-Uitterhoeve L, Sculier J P, Van Zandwijk N, Bartelink H. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 1992; 326: 524–530
   PubMed Web of Science ®Google Scholar
• Vokes E E, Weichselbaum R R. Concomitant chemoradiotherapy: Rationale and clinical experience in patients with solid tumors. J Clin Oncol 1990; 8: 911–934
   PubMed Web of Science ®Google Scholar
• Vokes E E. Interactions of chemotherapy and radiation. Semin Oncol 1993; 20: 70–79
   PubMed Web of Science ®Google Scholar
• Green M R, Kramar A, Schilsky R, Stoopler M, Zimmer B, Richards F, Skarin A, Anderson J R. Platinum-based combination chemotherapy in advanced non-small cell lung cancer: A randomized phase II trial of the Cancer and Leukemia Group B. Med Pediatr Oncol 1990; 18(3)197–202
   PubMedGoogle Scholar
• Richards F, II, Perry D J, Goutsou M, Modeas C, Muchmore E, Rege V, Chahinian A P, Hirsh V, Poiesz B, Green M R. Chemotherapy with 5-fluorouracil and cisplatin or 5-FU, cisplatin, and vinblastine for advanced non-small cell lung cancer. A randomized phase II study of the Cancer and Leukemia Group B. Cancer 1991; 67: 2974–2979
   PubMed Web of Science ®Google Scholar
• Citron M L, Modeas C, Propert K, Goutsou M, Green M R. Phase II trial of high-dose 24-hour continuous intravenous 5-fluorouracil for advanced non-small cell lung cancer. A Cancer and Leukemia Group B study. Cancer Invest 1992; 10(3)215–219
   PubMed Web of Science ®Google Scholar
• Vokes E E, Lyss A P, Herndon J E, II, Cooper B, Perry M C, Vinciguerra V, Mason-Coughlin K, Green M R. Intravenous 6-thioguanine or cisplatin, fluorouracil and leucovorin for advanced non-small cell lung cancer: A randomized phase II study of the cancer and leukemia group B. Ann Oncol 1992; 3: 727–732
   PubMed Web of Science ®Google Scholar
• Lynch T J, Jr., Kalish L A, Kass F, Strauss G, Elias A, Skarin A, Shulman L, Sugarbaker D, Frei E. Continuous-infusion cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer. Cancer 1994; 73: 1171–1176
   PubMed Web of Science ®Google Scholar
• Kreisman H, Ginsberg S, Propert K J, Richards F, Graziano S, Green M. Carboplatin or iproplatin in advanced non-small cell lung cancer: A Cancer and Leukemia Group B study. Cancer Treat Rep 1987; 71: 1049–1052
   PubMedGoogle Scholar
• Green M R, Kreisman H, Doll D C, Lyss A P, Clamon G H, Goutsou M, Perry M C, Propert K J. Carboplatin in non-small cell lung cancer: An update on the Cancer and Leukemia Group B experience. Semin Oncol 1992; 19(1 Suppl 2)44–49
   PubMedGoogle Scholar
• Lyss A P, Perry M C, Goutsou M, Propert K, Hemdon J E, II, Mason-Coughlin K, Green M R. Intensive etoposide and carboplatin chemotherapy for advanced non-small cell lung cancer. A phase II trial of the Cancer and Leukemia Group B. Am J Clin Oncol 1992; 15(5)399–404
   PubMed Web of Science ®Google Scholar
• Doll D C, Goutsou M, Grazianos, et al. Carboplatin and vinblastine in advanced non-small cell lung cancer: A phase II study. Cancer Chemother Pharmacol 1991; 29: 71–74
   PubMed Web of Science ®Google Scholar
• Graziano S L, Herndon J E, II, Richards F, II, DiFino S, Modeas C, Duggan D B, Green M R. A phase I trial of ifosfamide, mesna, and cisplatin in advanced non-small cell lung cancer: A Cancer and Leukemia Group B study. Cancer 1993; 72: 62–68
   PubMed Web of Science ®Google Scholar
• Graziano S L, Valone F H, Herndon J E, II, Crawford J, Richards F, II, Rege V B, Clamon G, Green M R. A randomized phase li study of ifosfamide/mesna/cisplatin plus G-CSF or etoposide/cisplatin plus G-CSF in advanced non-small cell lung cancer: A Cancer and Leukemia Group B study. Lung Cancer 1996; 14: 315–329
   PubMed Web of Science ®Google Scholar
• Kosty M P, Fleishman S B, Herndon J E, II, et al. Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small cell lung cancer: A randomized placebo-controlled, double-blind phase III study of the Cancer and Leukemia Group B. J Clin Oncol 1994; 12: 1113–1120
   PubMed Web of Science ®Google Scholar
• Chlebowski R T, Bulcavage I, Grosvenor M, et al. Hydrazine sulfate influence on nutritional status and survival in non-small cell lung cancer. J Clin Oncol 1990; 8: 9–15
   PubMed Web of Science ®Google Scholar
• Loprinzi C L, Goldberg R M, Su J Q, et al. Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer. J Clin Oncol 1994; 12: 1126–1129
   PubMed Web of Science ®Google Scholar
• Herbert V. Three stakes in hydrazine sulfate's heart, but questionable cancer remedies, like vampires, always rise again. J Clin Oncol 1994; 12: 1107–1108, (editorial)
   PubMed Web of Science ®Google Scholar
• Masters G A, Hoffman P C, Drinkard L C, Watson S, Samuels S, Golomb H M, Vokes E E. Preliminary report on a phase I study of ifosfamide and vinorelbine (Navelbine) in advanced non-small cell lung cancer. Semin Oncol 1996; 23(Suppl 5)11–18
   Google Scholar
• Hoffman P C, Masters G A, Drinkard L C, Krauss S A, Samuels B, Golomb H, Vokes E E. Ifosfamide plus paclitaxel in advanced non-small cell lung cancer: A phase I study. Ann Oncol 1996; 7: 314–316
   PubMed Web of Science ®Google Scholar
• Seagren S L, Herndon J E, Baeker J R, et al. Alternating irradiation and chemotherapy in stage III A and B nonsmall cell lung cancer: Report of a Cancer and Leukemia Group B Phase II Study 8636. Int J Radiat Oncol Biol Phys 1994; 29: 1085–1088
   PubMed Web of Science ®Google Scholar
• Kreisman H, Lisbona A, Olson L, Propert K J, Modeas C, Dillman R O, Seagren S L, Green M R. Effect of radiologic stage III sub-stage on nonsurgical therapy of non-small cell lung cancer. Cancer 1993; 72: 1588–1596
   PubMed Web of Science ®Google Scholar
• Dillman R O, Herndon J, Seagren S L, Eaton W L, Green M R. Improved survival in stage III non-small-cell lung cancer: Seven year follow-up of Cancer and Leukemia Group B (CALGB) 8433 trial. J Natl Cancer Inst 1996; 88: 1210–1215
   PubMed Web of Science ®Google Scholar
• Clamon G, Herndon J, Eaton W, et al. A feasibility study of extended chemotherapy for locally advanced non-small cell lung cancer: A phase II trial of Cancer and Leukemia Group B. Cancer Invest 1994; 12(3)273–281
   PubMed Web of Science ®Google Scholar
• Lilenbaum R C, Green M R. Novel chemotherapeutic agents in the treatment of non-small-cell lung cancer. J Clin Oncol 1993; 11: 1391–1402
   PubMed Web of Science ®Google Scholar
• Vokes E E. Integration of vinorelbine into current chemotherapy strategies for advanced non-small cell lung cancer. Oncology 1995; 9: 565–577
   PubMedGoogle Scholar
• Vokes E E, Haraf D J, Masters G A, Hoffman P C, Drinkard L C, Ferguson M, Olak J, Watson S, Golomb H M. Vinorelbine (Navelbine), cisplatin, and concomitant radiation therapy for advanced malignancies of the chest: A phase I study. Semin Oncol 1996; 23(Suppl 5)48–52
   PubMedGoogle Scholar
• Meyer J T, Spencer S A, Jennelle R LS, Kim R Y, Meredith R F, Wheeler R H, Robert F. Phase I study of concurrent taxol/cisplatin with thoracic radiation (TR) in locally advanced non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 1996; 15: 372, (abstract #1104)
   Google Scholar
• Strauss G M, Herndon J E, Sherman D D, Mathisen D J, Carey R W, Choi N C, Rege V B, Modeas C, Green M R. Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: Report of a Cancer and Leukemia Group B phase II study. J Clin Oncol 1992; 10: 1237–1244
   PubMed Web of Science ®Google Scholar
• Sugarbaker D, Herndon J, Kohman L, et al. Patterns of recurrence in CALGB 8935, a tri-modality trial for IIIA (N2) non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 1994; 13: 348, (abstract #1165)
   Google Scholar
• Roth J A, Fossella F, Komaki R, et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable IIIA non-small-cell lung cancer. J Natl Cancer Inst 1994; 86: 673–680
   PubMed Web of Science ®Google Scholar
• Rosell R, Gomez-Codina J, Camps C, et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med 1994; 330: 153–158
   PubMed Web of Science ®Google Scholar